Bryborn Malin, Halldén Christer, Säll Torbjörn, Adner Mikael, Cardell Lars Olaf
Laboratory of Clinical and Experimental Allergy Research, Department of Otorhinolaryngology, Malmö University Hospital, LundUniversity, Malmö, Sweden.
Respir Res. 2008 Mar 28;9(1):29. doi: 10.1186/1465-9921-9-29.
S100A7 is a calcium-binding protein with chemotactic and antimicrobial properties. S100A7 protein levels are decreased in nasal lavage fluid from individuals with ongoing allergic rhinitis, suggesting a role for S100A7 in allergic airway inflammation. The aims of this study were to describe genetic variation in S100A7 and search for associations between this variation and allergic rhinitis.
Peripheral blood was collected from 184 atopic patients with a history of pollen-induced allergic rhinitis and 378 non-atopic individuals, all of Swedish origin. DNA was extracted and the S100A7 gene was resequenced in a subset of 47 randomly selected atopic individuals. Nine polymorphisms were genotyped in 184 atopic and 378 non-atopic individuals and subsequently investigated for associations with allergic rhinitis as well as skin prick test results. Haplotypes were estimated and compared in the two groups.
Thirteen polymorphisms were identified in S100A7, of which 7 were previously undescribed. rs3014837 (G/C), which gives rise to an Asp --> Glu amino acid shift, had significantly increased minor allele frequency in atopic individuals. The major haplotype, containing the major allele at all sites, was more common in non-atopic individuals, while the haplotype containing the minor allele at rs3014837 was equally more common among the atopic individuals. Additionally, heterozygotes at this site had significantly higher scores in skin prick tests for 9 out of 11 tested allergens, compared to homozygotes.
This is the first study describing genetic variation, associated with allergy, in S100A7. The results indicate that rs3014837 is linked to allergic rhinitis in our Swedish population and render S100A7 a strong candidate for further investigations regarding its role in allergic inflammation.
S100A7是一种具有趋化和抗菌特性的钙结合蛋白。持续性变应性鼻炎患者鼻灌洗液中S100A7蛋白水平降低,提示S100A7在变应性气道炎症中起作用。本研究的目的是描述S100A7的基因变异,并寻找这种变异与变应性鼻炎之间的关联。
收集了184例有花粉诱导的变应性鼻炎病史的特应性患者和378例非特应性个体的外周血,所有个体均为瑞典裔。提取DNA,并对47例随机选择的特应性个体的子集进行S100A7基因重测序。在184例特应性个体和378例非特应性个体中对9个多态性进行基因分型,随后研究其与变应性鼻炎以及皮肤点刺试验结果的关联。估计并比较两组的单倍型。
在S100A7中鉴定出13个多态性,其中7个是以前未描述的。导致天冬氨酸→谷氨酸氨基酸移位的rs3014837(G/C)在特应性个体中的次要等位基因频率显著增加。在所有位点均包含主要等位基因的主要单倍型在非特应性个体中更常见,而在rs3014837处包含次要等位基因的单倍型在特应性个体中同样更常见。此外,与纯合子相比,该位点的杂合子在11种测试变应原中的9种皮肤点刺试验中得分显著更高。
这是第一项描述S100A7中与过敏相关的基因变异的研究。结果表明,rs3014837与我们瑞典人群中的变应性鼻炎相关,并使S100A7成为进一步研究其在变应性炎症中作用的有力候选者。